What medications should be stopped before Radioactive Iodine (RAI) treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Medications to Stop Before Radioactive Iodine (RAI) Therapy

Antithyroid Medications Must Be Discontinued

Stop methimazole and propylthiouracil (PTU) at least 3-7 days before RAI administration to prevent interference with radioiodine uptake and avoid precipitating thyroid storm from abrupt withdrawal. 1, 2

Critical Timing Considerations:

  • Antithyroid drugs (methimazole, PTU) should be discontinued 3-7 days prior to RAI to allow adequate iodine uptake while minimizing risk of thyroid storm from medication withdrawal. 1, 2

  • The patient must be biochemically euthyroid before stopping antithyroid medications - RAI should never be administered in an uncontrolled hyperthyroid state, as post-radiation thyrocyte destruction can trigger massive thyroid hormone release and precipitate thyroid storm. 2

  • In high-risk patients (children, severe hyperthyroidism), consider shorter withdrawal periods (3-4 days) rather than longer ones to reduce thyroid storm risk, as demonstrated by a case of thyroid storm occurring 13 days after methimazole withdrawal. 1

Levothyroxine Management for Thyroid Cancer Patients

If using thyroid hormone withdrawal (THW) method for TSH stimulation, stop levothyroxine 3-4 weeks before RAI and liothyronine 2 weeks before RAI. 3, 4

  • However, recombinant human TSH (rhTSH/Thyrogen) is the preferred preparation method because it allows patients to continue levothyroxine therapy while achieving equivalent TSH stimulation (≥30 mIU/L), avoiding hypothyroid morbidity entirely. 3, 4, 5

  • The standard rhTSH protocol is 0.9 mg IM on Day 1 and Day 2, followed by RAI on Day 3, with patients maintaining their levothyroxine throughout. 3, 4

Medications That Interfere With Iodine Uptake

Stop all iodine-containing medications and supplements at least 1-2 weeks before RAI:

  • Amiodarone (requires 3-6 months clearance due to long half-life)
  • Iodinated contrast agents (CT contrast - wait 4-8 weeks)
  • Multivitamins containing iodine
  • Kelp and seaweed supplements
  • Topical iodine preparations
  • Expectorants containing iodine

Note: While not explicitly detailed in the provided guidelines, this represents standard clinical practice based on the mechanism requiring adequate TSH stimulation and iodine uptake. 3, 4

Common Pitfall to Avoid

The most dangerous error is administering RAI to patients in an uncontrolled hyperthyroid state - this can precipitate life-threatening thyroid storm from radiation-induced thyroid hormone release. Always ensure biochemical euthyroid status before antithyroid drug withdrawal and RAI administration. 1, 2

References

Guideline

TSH Stimulation for Radioactive Iodine Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Radioactive Iodine Treatment Procedure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Radioactive Iodine Therapy in Thyroid Cancer Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.